BIGBEAR
PHARMACEUTICAL
Its unique characteristic is the ability to penetrate the blood-brain barrier, rendering it effective against tumors with central nervous system metastases.
AuthenticGuaranteeFast DeliveryPrivacy Indications for entrectinib:1. For the treatment of adult patients with ROS1-positive metastatic non-small cell lung cancer (NSCLC) confirmed by an FD···【More】
Update: 24 Mar,2026Source: BigbearViews: 101
Patients should be aware of adverse reactions occurring during entrectinib use. If symptoms are severe, consult a doctor promptly for dosage adjustmen···【More】
Update: 24 Mar,2026Source: BigbearViews: 101
Due to significant individual differences among cancer patients, including tumor molecular characteristics, physical function, and comorbidities, drug···【More】
Update: 24 Mar,2026Source: BigbearViews: 94
Entrectinib is a targeted anticancer drug primarily used to treat solid tumors and lymphomas carrying specific gene mutations. Common side effects inc···【More】
Update: 09 Mar,2026Source: BigbearViews: 93
Entrectinib is a targeted anticancer drug primarily used to treat solid tumors and lymphomas carrying specific gene mutations. Common side effects inc···【More】
Update: 09 Mar,2026Source: BigbearViews: 93
Entrectinib is a targeted therapy for NTRK gene fusion-positive solid tumors and ROS1-positive non-small cell lung cancer. Its price varies depending ···【More】
Update: 09 Mar,2026Source: BigbearViews: 96
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
